Context makes a T cell engager deal; Ginkgo Bioworks backers have a new SPAC

Plus, news about Longevity Biomedical, Sensorion, Teva and Bristol Myers Squibb:

Context Therapeutics buys a T cell engager: The biotech will

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Selkirk Pharma announces new APS qualified facility with advanced fill/finish capacity in Spokane, WA

Selkirk Pharma, Inc., a privately held U.S. pharmaceutical manufacturer specializing in the fill and finish of injectable drugs, including vaccines and biological therapeutics, today announced

February 22, 2024

Abivax announces the resumption of its liquidity contract – Biotech Investments

EQS-News: ABIVAX / Key word(s): Miscellaneous Abivax announces the resumption of its liquidity contract 21.11.2023 / 08:30 CET/CEST The issuer is solely responsible for the

November 22, 2023

Vera’s $300M offering; Abeona resubmits treatment for rare skin disease

Plus, news about Astellas, Clover, ElevateBio, Monopar, Idorsia and Neurocrine Biosciences: Vera Therapeutics plans $300M offering: The California biotech is Sign up to read this

October 30, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.